Case Studies
ABS-201 Case Study
Publications
Origin-1: a generative AI platform for de novo antibody design against novel epitopes
ABS-201 Case Study: Potential best-in-class antibody targeting the prolactin receptor for the treatment of androgenic alopecia
IgDesign: In vitro validated antibody design against multiple therapeutic antigens using inverse folding
Development of ABS-101: A potential best-in-class anti-TL1A antibody for the treatment of IBD
